We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Nanolaminate Coating Extends Viability of Microimplants

By HospiMedica International staff writers
Posted on 01 Jan 2019
A novel atomic layer deposition (ALD) thin film coating can encapsulate minuscule electronic implants, extending their lifetime in the human body.

The Picosun (Espoo, Finland) PicoMEDICAL nanolaminate encapsulant is intended to provide reliable, hermetic sealing of implantable medical devices, ranging from micro-scale neural stimulators, diagnostic sensors, blood glucose sensors, intraocular, intracranial, and blood pressure monitors, and even artificial eyesight. More...
The coating can also be applied to larger items, such as hip, knee, and dental implants. The thin film ALD coating is intrinsically biocompatible and remains inert inside the human body, uniformly covering even complex three-dimensional (3D) structures with nanoscale details.

Such minuscule devices are typically implanted for extended periods of time--from several months to well over ten years--making protection of their sensitive electronics against the corrosive environment inside the human body crucial. The opposite is also true; the body has to be protected against possible inflammatory reactions or immune rejection caused by the implant. Traditional encapsulation materials, such as titanium metal, ceramics, and polymers such as polyimide are suitable for larger implants such as pacemakers and orthopedic implants, but when size diminishes, novel encapsulation methods and materials are called for.

“There is an increasing number of customers in the healthcare industries that are now looking at ALD to solve some critical issues in their products. We at Picosun have developed a whole family of production-proven, turn-key PicoMEDICAL solutions specifically to answer this need,” said Jani Kivioja, PhD, CTO of Picosun Group. “The excellent results of our ALD encapsulation for biomedical microimplants prove that our technological knowhow and decades of experience in the field are now paving the way for a whole new generation of ALD-enabled healthcare solutions.”

ALD is a thin-film deposition technique based on sequential use of gas phase chemical vapor deposition. The majority of ALD reactions use two chemicals precursors that react with the surface of a material one at a time in a sequential, self-limiting, manner. Through the repeated exposure to separate precursors, a thin film is slowly deposited. ALD is a key process in the fabrication of semiconductor devices, and can also be applied at relatively low temperatures, which advocates their use on sensitive materials such as plastics and polymers.

Related Links:
Picosun


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.